Genetic analysis of the CYP21A2 gene in neonatal dried blood spots from children with transiently elevated 17-hydroxyprogesterone

被引:5
|
作者
Malikova, Jana [2 ]
Votava, Felix [3 ,4 ]
Vrzalova, Zuzana [5 ,6 ]
Lebl, Jan [1 ,2 ]
Cinek, Ondrej [2 ]
机构
[1] Univ Hosp Motol, Dept Pediat, CZ-15006 Prague, Czech Republic
[2] Charles Univ Prague, Dept Pediat, Fac Med 2, Prague, Czech Republic
[3] Charles Univ Prague, Dept Pediat, Fac Med 3, Prague, Czech Republic
[4] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic
[5] Univ Hosp, Ctr Mol Biol & Gene Therapy, Brno, Czech Republic
[6] Masaryk Univ, Brno, Czech Republic
关键词
CONGENITAL ADRENAL-HYPERPLASIA; STEROID 21-HYDROXYLASE DEFICIENCY; SEQUENCE VARIANTS; DIAGNOSIS; MUTATION; ASSAY;
D O I
10.1111/j.1365-2265.2012.04358.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Neonatal screening for congenital adrenal hyperplasia (CAH) identifies a certain proportion of newborns with transient moderate elevation of 17-hydroxyprogesterone (17-OHP). These children require regular follow-up until normalization of their 17-OHP levels. We investigated the possibility of reducing the individuals' recall rates by using genetic methods on their original neonatal dried blood spots. Patients and Methods We analysed neonatal dried blood spots from 753 subjects with transiently elevated levels of 17-OHP. The CYP21A2 gene was sequenced to detect point mutations, and the presence of CYP21A2 was further confirmed by two methods utilizing the difference between CYP21A2 and its CYP21A1P pseudogene in the sequence of exon 3 (8-bp deletion). The accuracy of the methods was verified using samples from 70 subjects with known CYP21A2 mutations and 181 healthy children. Result Among the 701 successfully sequenced samples from subjects with transiently elevated 17-OHP, 670 (95%) had no point mutations or novel variants in the CYP21A2 gene. We found no individuals carrying genotypes consistent with the diagnosis of CAH (i.e. homozygotes or compound heterozygotes for point mutations, large deletions or rearrangements). However, 21 heterozygous carriers of known point mutations that cause the classic and nonclassic forms of CAH were identified. Additionally, we detected eight heterozygous and two homozygous point variants with unknown functional significance. Conclusion Although CAH caused by 21-hydroxylase deficiency could be genetically excluded with a reasonable degree of confidence in 95% of the genotyped subjects that had transiently elevated 17-OHP, the performance of the tests was suboptimal when performed using dried blood spots and time-consuming in comparison with the current practice of repeated measurements of 17-OHP. The introduction of this method into clinical practice seems to be impractical at this stage.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 28 条
  • [21] Extraction of 17-hydroxyprogesterone (17-OHP) from dried blood spots with diethylether prior to standard ELISA-test significantly reduces the false positive rate in newborn screening for congenital adrenal hyperplasia (CAH)
    Fingerhut, R.
    Olgemoeller, B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 8 - 8
  • [22] Congenital adrenal hyperplasia in paediatric age<:> molecular analysis of the CYP21A2 gene and implications for genetic counselling
    Gomes, S.
    Silva, J.
    Pereira-Caetano, I.
    Lopes, L.
    Limbert, C.
    Amaral, D.
    Pina, R.
    Kay, T.
    Sampaio, L.
    Pereira, C.
    Moldovan, O.
    Sousa, A. B.
    Rebelo, I.
    Gaspar, I.
    Rodrigues, J. C.
    Ramos, F.
    Ramos, L.
    Dinis, I.
    Cardoso, R. C.
    Mirante, A.
    Goncalves, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 483 - 483
  • [23] Combined in vitro and in silico analysis of 21-hydroxylase gene mutations is a valuable tool for genetic counselling - analysis of six novel CYP21A2 sequence variants
    Parajes, Silvia
    Loidi, Lourdes
    Dhir, Vivek
    Morey, Marcos
    Dominguez, Fernando
    Arlt, Wiebke
    Krone, Nils
    HORMONE RESEARCH, 2009, 72 : 363 - 363
  • [24] Analysis of the CYP21A2 gene pathogenic variants in CAH patients from Surgut using next-generation sequencing (NGS)
    Osinovskaya, Natalia
    Vashukova, Elena
    Tarasenko, Olga
    Danilova, Maria
    Glavnova, Olga
    Sultanov, Iskender
    Donnikov, Maxim
    Nasykhova, Yulia
    Glotov, Andrey
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2024, 25 (01)
  • [25] Analysis of the CYP21A2 gene pathogenic variants in CAH patients from Surgut using next-generation sequencing (NGS)
    Natalia Osinovskaya
    Elena Vashukova
    Olga Tarasenko
    Maria Danilova
    Olga Glavnova
    Iskender Sultanov
    Maxim Donnikov
    Yulia Nasykhova
    Andrey Glotov
    Egyptian Journal of Medical Human Genetics, 25
  • [26] Analysis of the GH content within archived dried blood spots of newborn screening cards from children diagnosed with growth hormone deficiency after the neonatal period
    Binder, G.
    Hettmann, S.
    Weber, K.
    Kohlmueller, D.
    Schweizer, R.
    GROWTH HORMONE & IGF RESEARCH, 2011, 21 (06) : 314 - 317
  • [27] Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia:: Identification, functional characterization, and structural analysis
    Grischuk, Yulia
    Rubtsov, Petr
    Riepe, Felix G.
    Groetzinger, Joachim
    Beljelarskaia, Svetlana
    Prassolov, Vladimir
    Kalintchenko, Natalya
    Semitcheva, Tatyana
    Peterkova, Valentina
    Tiulpakov, Anatoly
    Sippell, Wolfgang G.
    Krone, Nils
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (12): : 4976 - 4980
  • [28] Study of Human Leukocyte Antigen (HLA) in 13 cases of familial frontal fibrosing alopecia: CYP21A2 gene p.V281L mutation from congenital adrenal hyperplasia linked to HLA class I haplotype HLA-A*33:01; B*14:02; C*08:02 as a genetic marker
    Librada Porrino-Bustamante, Maria
    Angel Lopez-Nevot, Miguel
    Aneiros-Fernandez, Jose
    Casado-Ruiz, Jorge
    Garcia-Linares, Susana
    Pedrinacci-Rodriguez, Susana
    Garcia-Lora, Elena
    Antonia Martin-Casares, Maria
    Antonia Fernandez-Pugnaire, Maria
    Arias-Santiago, Salvador
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (03) : E195 - E200